Premier, Inc. (PM8.F)
| Previous close | 32.60 |
| Open | 31.00 |
| Bid | 0.00 x 30000 |
| Ask | 0.00 x 30000 |
| Day's range | 31.00 - 32.60 |
| 52-week range | 25.80 - 32.60 |
| Volume | |
| Avg. volume | 4 |
| Market cap | 4.023B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 14.66 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 14, 2024
CHARLOTTE, N.C., May 09, 2024--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the BofA Securities Healthcare Conference on Tuesday, May 14, 2024, at 9:20 a.m. PDT (12:20 p.m. EDT).
- Business Wire
Premier, Inc. Announces Cross-Industry Initiative to Improve Diagnosis and Care for Chronic Kidney Disease
CHARLOTTE, N.C., May 08, 2024--Premier, Inc. (NASDAQ: PINC) is excited to announce a strategic partnership with AstraZeneca called Uncover CKD - Care Collective aiming to identify patients with undiagnosed clinical chronic kidney disease (CKD); raise awareness of undiagnosed CKD among healthcare providers; and inform U.S. health systems that want to improve or develop and implement their strategies for CKD diagnosis, treatment and management.
- Business Wire
Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results
CHARLOTTE, N.C., May 07, 2024--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 third quarter ended March 31, 2024.
